DeepMed Research

Insel Gruppe AG

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: Private

Established: 2016-01-01

Employees: 10K

Market Cap: -

Website: https://www.inselgruppe.ch

Clinical Trials

Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention

Phase 2

Recruiting

Conditions: Kidney Stone

Interventions: Drug: Indapamide 2.5 MG
Drug: Hydrochlorothiazide 50Mg
Drug: Chlorthalidone 25mg

First Posted Date: 2023-11-01

Last Posted Date: 2025-02-19

Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Target Recruit Count: 99

Registration Number: NCT06111885

Locations: 🇨🇭
Inselspital, Department of Nephrology and Hypertension, Bern, Switzerland

Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study

Recruiting

Conditions: Embolic Stroke of Undetermined Source
Occult Cancer
Ischemic Stroke
D-dimer
Cancer-related Stroke
Paraneoplastic Coagulopathy

First Posted Date: 2023-10-25

Last Posted Date: 2024-12-13

Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Target Recruit Count: 370

Registration Number: NCT06100718

Locations: 🇨🇭
Dept, of Neurology, Inselspital, University of Bern, Bern, Switzerland
🇨🇭
Dept. of Neurology, Centre Hospital Universitaire Vaudois, Lausanne, Vaud, Switzerland
🇨🇭
Dept. of Neurology, Universitätsspital Basel, Basel, Switzerland

MRI-based 3D Hip Labrum and Cartilage Morphology in Patients With Hip Deformities Compared to Asymptomatic Volunteers

Recruiting

Conditions: Hip Disease

Interventions: Other: Magnetic Resonance Imaging (MRI) of the hip with intra-articular contrast agent
Other: Non- contrast Magnetic Resonance Imaging (MRI) of the hip

First Posted Date: 2023-10-23

Last Posted Date: 2023-10-23

Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Target Recruit Count: 60

Registration Number: NCT06095219

Locations: 🇨🇭
University Hospital of Bern (Inselspital), Bern, Switzerland

Closed Incision Negative Pressure Wound Therapy for the Prevention of Surgical Site Infections in Abdominal Surgery

Not Applicable

Not yet recruiting

Conditions: Surgical Wound Infection

Interventions: Device: Closed incision negative pressure wound therapy
Device: Standard dressing

First Posted Date: 2023-10-05

Last Posted Date: 2024-12-05

Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Target Recruit Count: 654

Registration Number: NCT06068517

Locations: 🇨🇭
Inselspital, Bern University Hospital, Bern, Switzerland

B-free Multistage Trial

Phase 4

Conditions: HIV
Drug Resistance
Drug Drug Interaction

Interventions: Drug: DOR/DTG/3TC

First Posted Date: 2023-09-14

Last Posted Date: 2024-12-04

Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Target Recruit Count: 210

Registration Number: NCT06037564

Locations: 🇨🇭
Inselgruppe AG, Bern, Switzerland
🇨🇭
University Hospital Geneva, Geneva, Switzerland
🇨🇭
University of Lausanne Hospitals, Lausanne, Switzerland

and more 5 locations

Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures

Not Applicable

Withdrawn

Conditions: Leg Ulcer

Interventions: Device: Kerecis Omega 3
Procedure: Surgical debridement

First Posted Date: 2023-09-14

Last Posted Date: 2024-12-06

Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Registration Number: NCT06036485

Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea

Phase 2

Completed

Conditions: Rosacea

Interventions: Device: KTP laser
Drug: Ivermectin 1% cream

First Posted Date: 2023-09-13

Last Posted Date: 2024-12-06

Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Target Recruit Count: 22

Registration Number: NCT06033352

Locations: 🇨🇭
Department of dermatology, University Hospital Inselspital, Bern, Bern, Switzerland

Involvement of the Gut Microbiota in Calcified Aortic Stenosis

Not yet recruiting

Conditions: Gastrointestinal Microbiome
Metabolomics
Aortic Stenosis

Interventions: Other: No intervention

First Posted Date: 2023-09-01

Last Posted Date: 2023-09-01

Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Target Recruit Count: 100

Registration Number: NCT06021535

The PIFPAF-PFA Study

Not Applicable

Active, not recruiting

Conditions: Persistent Atrial Fibrillation

Interventions: Procedure: Pulmonary vein isolation without posterior wall ablation
Procedure: Pulmonary vein isolation with posterior wall ablation

First Posted Date: 2023-08-14

Last Posted Date: 2025-02-18

Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Target Recruit Count: 206

Registration Number: NCT05986526

Locations: 🇨🇭
Cantonal Hospital Baden, Baden, Switzerland
🇨🇭
University Hospital Basel, Basel, Switzerland
🇨🇭
Inselspital, University Hospital Bern, Bern, Switzerland

and more 3 locations

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

Not Applicable

Recruiting

Conditions: Ischemic Stroke
Atrial Fibrillation

Interventions: Drug: DOAC
Procedure: Left atrial appendage Occlusion

First Posted Date: 2023-08-04

Last Posted Date: 2025-04-18

Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Target Recruit Count: 482

Registration Number: NCT05976685

Locations: 🇧🇪
HUmani CHU Charleroi-Chimay, Charleroi, Belgium
🇧🇪
Universitair Ziekenhuis (UZ) Leuven, Leuven, Belgium
🇩🇪
Universitätsmedizin Göttingen, Göttingen, Germany

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy